The Charitable Trust managed by Jim Cramer is trimming its stake in Broadcom as political friction mounts against data center development. The portfolio sold 165 shares of the semiconductor firm on August 24, 2026, at a price of roughly $361.27 per share. This move cuts the fund's Broadcom exposure in half, taking the weight down to 1.5% from 3%. By offloading these shares, the trust secures a profit of approximately 323% on an investment that originated in late 2023.
Shifts in the Political Landscape
Recent actions taken by state leadership signal a new hurdle for AI infrastructure. Governors in Texas and Pennsylvania have started to scrutinize data center projects with increased intensity. They are now demanding more detailed disclosures from developers to weed out speculative projects. This pivot comes as the midterm elections approach in November. Markets expect this political pressure to suppress new capital investment for the immediate future.
Cramer cited these state-level policy changes as the primary catalyst for the sale. The goal is to protect gains from potential volatility if the construction pipeline slows. The team is currently weighing whether to reduce other infrastructure holdings linked to the AI build-out.
Strategic Reallocation to Healthcare
Proceeds from the Broadcom sale are funding an expansion into Cardinal Health. The trust acquired 50 shares at roughly $229.25 each. This move increases the position to 425 shares, representing 2.5% of the total portfolio value. Cardinal Health shares recently dipped 5% from an all-time high, creating what the managers view as a favorable entry point.
Strong quarterly performance serves as the basis for this purchase. Cardinal Health projects adjusted earnings growth between 13% and 15% for the 2027 fiscal year. This forecast suggests earnings per share between $12.40 and $12.60. Market consensus previously sat near $12.04. The stock trades at approximately 18 times its projected earnings, prompting an upgrade to a rating of 1 for the holding.
Future Market Implications
This rebalancing reflects a defensive shift toward established, cash-generating healthcare names. The broader data center trade faces structural risks beyond simple demand curves. If states continue to enforce stricter environmental and construction standards, companies relying on hyperscale expansion may face significant headwinds. Investors should watch for further state-level legislative shifts in the coming months. The trust remains committed to monitoring whether these regulatory pressures turn into a lasting drag on the tech sector.